Review of published reports of familial cases of mitochondrial myopathy suggests that the ratio of maternal to paternal transmission is about 9:1. We conclude that these disorders may be caused by mutations of either nuclear or mitochondrial genes.
The term mitochondrial myopathy (MM) is applied to a clinically and biochemically heterogeneous group of disorders which share the common feature of major mitochondrial structural abnormalities in skeletal muscle. Ragged red fibres, seen with the modified Gomori trichrome stain,' are the major morphological hallmark of these diseases. They were described initially in patients presenting with syndromes of chronic progressive external ophthalmoplegia (CPEO) or proximal myopathy or both, often with weakness induced or enhanced by exertion. More recently they have been reported in children and adults with complex multisystem disorders predominantly or exclusively affecting the central nervous system, giving rise to clinical features such as psychomotor retardation, dementia, pigmentary retinopathy, ataxia, seizures, movement disorders, stroke-like episodes, deafness, and peripheral neuropathy in various combinations. Involvement of other systems, such as the heart, endocrine glands, and haemopoietic tissues, has also been reported. 2 3 In vitro studies of mitochondrial metabolism in patients with MM have identified a variety of defects of the respiratory chain and oxidative phosphorylation system, none of which is associated with a specific or consistent clinical syndrome. [2] [3] [4] The majority of reported cases of MM have no affected relatives but families containing more than one affected subject have been described. It has Received for publication 11 August 1987. Revised version accepted for publication 23 September 1987. been suggested that MM is caused by mutations of mitochondrial DNA, as maternal transmission to offspring appears to be more common than paternal transmission, and mitochondrial DNA is exclusively maternally inherited. 5 6 This paper presents pedigree data on 71 patients with histologically defined MM and analyses 105 familial cases from published reports.
Patients and methods
The index cases were ascertained from the muscle biopsy files at the National Hospital for Nervous Diseases, London cousin with several normal intervening male relatives ( fig 3) .
Six further patients gave a history of affected relatives but these were unavailable for examination. The presence of ptosis was confirmed by examining hospital records and photographs of one patient's sister's daughter. The index case had CPEO and proximal weakness and complex III deficiency (case 1 of Petty et al3). A male with complex I deficiency and ataxia, personality change, and proximal muscle weakness developing in the third decade of life had an older brother who died at the age of 25. He was always small and of low intelligence. When he was 19 he had the first of several stroke-like episodes, associated with focal seizures, which led to progressive disability and dementia. The dead brother of an Iranian male with CPEO and proximal weakness was similarly affected; their parents were first cousins. In the four other cases the family history was vague and could not be confirmed; these relatives were not therefore considered as secondary cases. Two (one male, one female) had children with 'droopy eyelids', another Affected cousins with cytochrome c oxidase deficiency and apparently normal parents have been described. 48 In a number of other pedigrees it is difficult to be sure whether some subjects were affected or not and the pattern of transmission is unclear.6 11414-For example, the mothers and grandmother of two cousins with mitochondrial encephalomyopathy were deaf. 52 The mother of two sibs with myoclonus and MM had an abnormal EEG, and the mother of another similar case had frequent falls for about 10 years before her death aged 33.54 In a further kindred,49 the brother, father, and one cousin of a patient with CPEO and proximal myopathy had ptosis but no other neurological abnormalities; muscle biopsies were not performed on the relatives. In two families described by Bastiaensen et al, 1 which appear to show numerous examples of paternal transmission, all the patients, apart from the index cases, had only "slight ptosis". Muscle biopsy from one relative showed "minimal mitochondrial abnormalities". The father of two patients with proximal myopathy had mildly raised serum lactate concentrations.5 It is particularly difficult to assess the significance of abnormal investigations alone.
This problem is relevant to some of the families described by Egger and Wilson.6 In their family Gr, two clinically normal offspring of females were considered to be affected on the basis of raised creatine kinase levels, but similar findings in two daughters of male patients "were not viewed as indicative of mitochondrial cytopathy". In family Gal, three maternal relatives of the index case were considered to be affected because they had chronic nephropathy. Two patients in family H were diagnosed as having MM because increased jitter was found on single fibre electromyography. The mother The pedigree data obtained from published reports are summarised in table 4, together with the results of the present study. Familial cases of MM were confined to a single sibship in a total of 22 families and parental consanguinity was present in two of these. Forty-two mothers had affected children, compared to only seven fathers. Looking at the data in another way, which gives the total number of transmissions as opposed to parents, maternal transmission occurred 59 times compared to eight times for paternal transmission. Maternal transmission occurred exclusively in 27 out of the 33 families containing patients in two or more generations. Table 5 shows the ratio of affected:unaffected children of patients who had affected children in pedigrees exhibiting vertical transmission. It was impossible to exclude index cases as they could rarely be identified. Patients who had only unaffected children are shown separately, as ascertain- Isolated cases of MM, which comprise the majority of patients, could be the result of non-genetic phenocopies, autosomal recessive genes, fresh mutation of mitochondrial DNA, or new dominant mutations. There was no obvious increase in paternal age in this study to support the last possibility, although the data were not analysed statistically, mainly because of the paucity of data pertaining to normal paternal age over the relevant time. Paternal age in the UK during the first half of this century was slightly higher than that since 1960,74 so it is unlikely that there was a paternal age effect in this series. This does not exclude the possibility of fresh dominant mutation in some cases of MM. It is possible that mutation of mt DNA in ova occurs more frequently with increasing age, but again there was no evidence of a maternal age or birth order effect in this study.
The mitochondrial myopathies are clearly genetically heterogeneous and it appears likely that these diseases may be caused by defective mitochondrial, autosomal dominant, or autosomal recessive genes. Until the nature of these has been determined, it seems reasonable to use empirical recurrence risk estimates for genetic counselling.
